Rabbit Recombinant Monoclonal AIBZIP antibody. Carrier free. Suitable for WB and reacts with Human samples.
pH: 7.2 - 7.4
Constituents: PBS
IP | Flow Cyt | WB | IHC-P | |
---|---|---|---|---|
Human | Not recommended | Not recommended | Tested | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Transcriptional activator that may play a role in the unfolded protein response. Binds to the UPR element (UPRE) but not to CRE element. Preferentially binds DNA with to the consensus sequence 5'-T[GT]ACGT[GA][GT]-3' and has transcriptional activation activity from UPRE. Binds to NF-kappa-B site and has transcriptional activation activity from NF-kappa-B-containing regulatory elements (By similarity).
AIBZIP, CREB4, JAL, CREB3L4, Cyclic AMP-responsive element-binding protein 3-like protein 4, cAMP-responsive element-binding protein 3-like protein 4, Androgen-induced basic leucine zipper protein, Attaching to CRE-like 1, Cyclic AMP-responsive element-binding protein 4, Transcript induced in spermiogenesis protein 40, hJAL, AIbZIP, ATCE1, CREB-4, cAMP-responsive element-binding protein 4, Tisp40
Rabbit Recombinant Monoclonal AIBZIP antibody. Carrier free. Suitable for WB and reacts with Human samples.
pH: 7.2 - 7.4
Constituents: PBS
ab249051 is the carrier-free version of Anti-AIBZIP antibody [EPR7382] ab151736.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
AIBZIP also known as Activating Immune Response Protein BZIP is a transcription factor involved in regulating gene expression. This protein with a molecular mass of approximately 45 kDa plays an important role in cellular functioning. Researchers have observed AIBZIP expression mainly in the immune cells including B and T lymphocytes. It regulates genes involved in immune responses by binding to DNA at specific sites assisting in the control of gene transcription.
AIBZIP is a regulator of immune cell communication and response. AIBZIP forms a complex with other bZIP family proteins enabling it to influence a wide range of cellular processes. AIBZIP modulates expression of cytokines and other immunologically relevant genes. Proper function of AIBZIP ensures cells can effectively respond to pathogens and maintain immune homeostasis.
AIBZIP acts in the NF-kB signaling pathway and JAK-STAT pathway both important for immune response and inflammation regulation. It interacts with proteins like RelA in the NF-kB pathway which modulates inflammatory responses and STAT3 in the JAK-STAT pathway that affects cellular growth and differentiation. Through these pathways AIBZIP influences many immune system functions and contributes to the regulation of immune cell activity.
AIBZIP impacts conditions like autoimmune disorders and certain cancers. Dysregulation of AIBZIP can lead to improper immune responses contributing to autoimmune diseases such as lupus. It also links to cancerous processes by affecting the immune system’s ability to fight tumor cells interacting with proteins like p53 that are important for cell cycle regulation. Understanding these interactions can help in developing targeted therapies for such diseases.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using Anti-AIBZIP antibody [EPR7382] ab151736, the same antibody clone in a different buffer formulation.
All lanes: Western blot - Anti-AIBZIP antibody [EPR7382] (Anti-AIBZIP antibody [EPR7382] ab151736) at 1/1000 dilution
Lane 1: Human prostate cancer lysate at 10 µg
Lane 2: Human breast cancer lysate at 10 µg
Lane 3: PC3 cell lysate at 10 µg
Lane 4: LnCaP cell lysate at 10 µg
Lane 5: MCF7 cell lysate at 10 µg
Lane 6: T47D cell lysate at 10 µg
All lanes: Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 43 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com